血浆致动脉硬化指数在心血管疾病中的应用进展  

Progress on the application of atherogenic index of plasma in cardiovascular diseases

作　　者：陈明丹(综述) 邢艳(审校)[1] CHEN Mingdan;XING Yan(Department of Medical Laboratory,North Sichuan Medical College&Clinical Laboraton,Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan 637000,China)

机构地区：[1]川北医学院医学检验系,川北医学院附属医院检验科,四川省南充市637000

出　　处：《中国动脉硬化杂志》2020年第3期273-276,共4页Chinese Journal of Arteriosclerosis

摘　　要：心血管疾病(CVD)是一种严重威胁人类健康的疾病,如何较早发现并预防心血管事件的发生,是我们急需解决的问题。血浆致动脉硬化指数(AIP)是最近几年提出的CVD的独立预测指标,由血浆甘油三酯(TG)和高密度脂蛋白胆固醇(HDLC)比值的对数转换得出,即log[TG/HDLC]。相比既往单一指标而言,AIP更能综合反映血脂代谢水平,对于疾病的临床诊断及治疗监测意义重大。现就AIP在CVD中的应用进展予以综述。Cardiovascular disease(CVD)is a serious threat to human health.It is an urgent problem for clinicians to early detect and prevent the occurrence of cardiovascular events.Atherogenic index of plasma(AIP)is an independent predictor of CVD proposed in recent years.It is derived from the logarithm conversion of the ratio of triglyceride(TG)to high density lipoprotein cholesterol(HDLC),i.e.,log[TG/HDLC].Compared with the previous single index,AIP can more comprehensively reflect the level of lipid metabolism,which is of great significance for clinical diagnosis and treatment monitoring of diseases.This article reviews the application of AIP in CVD.

关 键 词：血浆致动脉硬化指数 心血管疾病 动脉粥样硬化 

分 类 号：R54[医药卫生—心血管疾病]